The PDUFA date for Xarelto in AF is on or around 11/5/11, ten months from the submission date (#msg-58447066). The FDA presumably nixed a priority review because Pradaxa is already approved in this indication.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”